je.st
news
Biogen Inc (BIIB) Rating Increased to Overweight at Piper Jaffray
2016-01-03 18:15:54| Biotech - Topix.net
In related news, CMO Alfred Sandrock sold 441 shares of the business's stock in a transaction that occurred on Friday, December 4th. The stock was sold at an average price of $277.00, for a total transaction of $122,157.00.
Tags: rating
increased
piper
overweight
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||